Related Experiment Video
Updated: Feb 9, 2026

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
Sulforaphane Augments Glutathione and Influences Brain Metabolites in Human Subjects: A Clinical Pilot Study
Thomas W Sedlak1, Leslie G Nucifora1, Minori Koga1
1Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Abstract:
Schizophrenia and other neuropsychiatric disorders await mechanism-associated interventions. Excess oxidative stress is increasingly appreciated to participate in the pathophysiology of brain disorders, and decreases in the major antioxidant, glutathione (GSH), have been reported in multiple studies. Technical cautions regarding the estimation of oxidative stress-related changes in the brain via imaging techniques have led investigators to explore peripheral GSH as a possible pathological signature of oxidative stress-associated brain changes. In a preclinical model of GSH deficiency, we found a correlation between whole brain and peripheral GSH levels. We found that the naturally occurring isothiocyanate sulforaphane increased blood GSH levels in healthy human subjects following 7 days of daily oral administration. In parallel, we explored the potential influence of sulforaphane on brain GSH levels in the anterior cingulate cortex, hippocampus, and thalamus via 7-T magnetic resonance spectroscopy. A significant positive correlation between blood and thalamic GSH post- and pre-sulforaphane treatment ratios was observed, in addition to a consistent increase in brain GSH levels in response to treatment. This clinical pilot study suggests the value of exploring relationships between peripheral GSH and clinical/neuropsychological measures, as well as the influences sulforaphane has on functional measures that are altered in neuropsychiatric disorders.
Insights
This study shows sulforaphane increases blood and brain glutathione (GSH) levels. This suggests sulforaphane may help address oxidative stress in neuropsychiatric disorders.
Area of Science:
- Neuroscience
- Biochemistry
- Clinical Research
Background:
- Oxidative stress and reduced glutathione (GSH) are implicated in neuropsychiatric disorders.
- Peripheral GSH is explored as a biomarker for brain oxidative stress.
- Preclinical models show correlation between brain and peripheral GSH.
Purpose of the Study:
- To investigate sulforaphane's effect on blood and brain GSH levels in humans.
- To explore the relationship between peripheral and brain GSH.
- To assess sulforaphane as a potential intervention for neuropsychiatric disorders.
Main Methods:
- A 7-day oral administration of sulforaphane in healthy human subjects.
- Measurement of blood GSH levels.
- 7-Tesla magnetic resonance spectroscopy to measure brain GSH in specific regions (anterior cingulate cortex, hippocampus, thalamus).
Main Results:
- Sulforaphane significantly increased blood GSH levels.
- A positive correlation was observed between blood and thalamic GSH levels post-treatment.
- Consistent increases in brain GSH levels were detected following sulforaphane administration.
Conclusions:
- Sulforaphane effectively increases both peripheral and brain glutathione levels.
- Peripheral GSH may serve as a reliable indicator of brain GSH status.
- Sulforaphane shows promise as a potential therapeutic agent for conditions involving oxidative stress.
Related Concept Videos
Bioavailability Study Design: Healthy Subjects Versus Patients
Pilot and Numeric Relaying
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Hypertension III: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Cable Subjected to Its Own Weight
A generalized loading function is employed to analyze a cable subjected to its own weight. This function considers the force acting along the cable's arc length rather than its projected length, providing a more accurate...

